RxDoctor Payments Data

Malini Nair

Psychiatry · Winchester, MANPI 1578731998

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $814 of the $1,165 with a category attached, or 69.9%. E.r. Squibb & Sons, L.L.C. accounts for 96.4% of it on its own, with 2 other manufacturers making up the rest.

$1,165in general payments, 2019–2025

Across 5 payments — averaging $232.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • Neurocrine Biosciences, Inc.$25
  • Teva Pharmaceuticals USA, Inc.$17
$1,567,216in research payments, 2019–2025

Across 34 payments — averaging $46,095 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$521K
  • Genentech, Inc.$377K
  • E.r. Squibb & Sons, L.L.C.$313K
  • UCB SA$283K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$73K

What the payments were for

  • Travel & lodging$81470%
  • Food & beverage$35030%

General payments by program year

20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,165 in reported general payments places this provider in the 85th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts →

Most prescribed under Part D

DrugClaimsCost to plans & patients
NamzaricMemantine Hcl/Donepezil Hcl14$16,116
Donepezil Hcl30$315

Paid to pharmacies, not to this prescriber.

Other psychiatry in Winchester

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →